Immunovant, Inc.(IMVT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

IMVT Immunovant, Inc.

交易中 07-22 13:46:28 EDT

28.00

+0.03

+0.11%

最高28.80	最低27.78	成交量34.26万
今开28.19	昨收27.97	日振幅3.65%
总市值40.93亿	流通市值18.24亿	总股本1.46亿
成交额963.15万	换手率0.53%	流通股本6,516万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"IMVT","market":"US","secType":"STK","nameCN":"Immunovant, Inc.","latestPrice":28,"timestamp":1721670373258,"preClose":27.97,"halted":0,"volume":342599,"delay":0,"floatShares":65158128,"shares":146180134,"eps":-1.877877,"marketStatus":"交易中","marketStatusCode":2,"change":0.03,"latestTime":"07-22 13:46:28 EDT","open":28.19,"high":28.8,"low":27.78,"amount":9631524.400687,"amplitude":0.036468,"askPrice":28.04,"askSize":408,"bidPrice":28,"bidSize":118,"shortable":3,"etf":0,"ttmEps":-1.877877,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1721678400000},"adr":0,"adjPreClose":27.97,"preHourTrading":{"tag":"盘前","latestPrice":27.97,"preClose":27.97,"latestTime":"09:14 EDT","volume":43,"amount":1200.609966,"timestamp":1721654091815},"postHourTrading":{"tag":"盘后","latestPrice":28,"preClose":27.97,"latestTime":"18:42 EDT","volume":16989,"amount":475246.83,"timestamp":1721428966870},"volumeRatio":0.525255,"impliedVol":0.662,"impliedVolPercentile":0.2351},"requestUrl":"/m/hq/s/IMVT","defaultTab":"news","newsList":[{"id":"2452436702","title":"Immunovant, Inc.盘中异动 股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452436702","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452436702?lang=zh_cn&edition=full","pubTime":"2024-07-18 23:55","pubTimestamp":1721318145,"startTime":"0","endTime":"0","summary":"北京时间2024年07月18日23时55分，Immunovant, Inc.股票出现波动，股价急速下挫5.00%。截至发稿，该股报28.48美元/股，成交量28.6487万股，换手率0.20%，振幅4.90%。Immunovant, Inc.股票所在的生物技术行业中，整体跌幅为2.09%。其相关个股中，Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Onconetix, Inc.、Silo Pharma, Inc.涨幅较大，Silo Pharma, Inc.、Salarius Pharmaceuticals, Inc.、Onconetix, Inc.较为活跃，换手率分别为2243.87%、2121.96%、1182.82%，振幅较大的相关个股有Silo Pharma, Inc.、Salarius Pharmaceuticals, Inc.、Onconetix, Inc.，振幅分别为93.33%、91.50%、86.24%。Immunovant, Inc.公司简介：Immunovant Inc.是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718235545aefa5a6a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718235545aefa5a6a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4588","IMVTU","BK4585","IMVTW","IMVT"],"gpt_icon":0},{"id":"2450363671","title":"Immunovant, Inc.盘中异动 股价大涨5.11%报31.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450363671","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450363671?lang=zh_cn&edition=full","pubTime":"2024-07-11 21:36","pubTimestamp":1720704991,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日21时36分，Immunovant, Inc.股票出现波动，股价急速拉升5.11%。截至发稿，该股报31.90美元/股，成交量4.1287万股，换手率0.03%，振幅2.50%。Immunovant, Inc.股票所在的生物技术行业中，整体跌幅为0.04%。其相关个股中，Kazia Therapeutics Limited、Okyo Pharma Ltd Com Npv 、Virpax Pharmaceuticals, Inc.涨幅较大，Salarius Pharmaceuticals, Inc.、Kazia Therapeutics Limited、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为265.25%、209.46%、178.13%，振幅较大的相关个股有Kazia Therapeutics Limited、Virpax Pharmaceuticals, Inc.、Lexeo Therapeutics, Inc.，振幅分别为40.41%、22.94%、15.15%。Immunovant, Inc.公司简介：Immunovant Inc.是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711213632af91dd7c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711213632af91dd7c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","IMVT","BK4139","IMVTW","IMVTU","BK4585"],"gpt_icon":0},{"id":"2450071112","title":"Immunovant, Inc.盘中异动 急速拉升5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450071112","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450071112?lang=zh_cn&edition=full","pubTime":"2024-07-10 02:41","pubTimestamp":1720550516,"startTime":"0","endTime":"0","summary":"北京时间2024年07月10日02时41分，Immunovant, Inc.股票出现波动，股价急速上涨5.01%。截至发稿，该股报29.04美元/股，成交量44.6068万股，换手率0.31%，振幅5.55%。Immunovant, Inc.股票所在的生物技术行业中，整体跌幅为0.60%。其相关个股中，Soligenix, Inc.、Cingulate Inc C/Wts 10/12/2026 、180 Life Sciences Corp.涨幅较大，Soligenix, Inc.、180 Life Sciences Corp.、Longeveron Inc.较为活跃，换手率分别为12816.63%、3133.66%、357.27%，振幅较大的相关个股有Soligenix, Inc.、180 Life Sciences Corp.、180 Life Sciences Corp C/Wts 07/11/2025，振幅分别为468.99%、196.29%、134.00%。Immunovant, Inc.公司简介：Immunovant Inc.是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407100241569681b353&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407100241569681b353&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4588","BK4585","IMVT","IMVTU","IMVTW"],"gpt_icon":0},{"id":"2448914777","title":"Immunovant, Inc.盘中异动 股价大涨6.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448914777","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448914777?lang=zh_cn&edition=full","pubTime":"2024-07-01 23:26","pubTimestamp":1719847562,"startTime":"0","endTime":"0","summary":"北京时间2024年07月01日23时26分，Immunovant, Inc.股票出现波动，股价大幅拉升6.34%。截至发稿，该股报28.08美元/股，成交量18.278万股，换手率0.13%，振幅4.51%。Immunovant, Inc.股票所在的生物技术行业中，整体涨幅为0.60%。其相关个股中，Senti Biosciences, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Eyenovia, Inc.涨幅较大，Senti Biosciences, Inc.、Geovax Labs, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为610.52%、171.20%、105.43%，振幅较大的相关个股有Senti Biosciences, Inc.、Cingulate Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 ，振幅分别为101.49%、65.56%、56.01%。Immunovant, Inc.公司简介：Immunovant Inc.是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701232602af900ad1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701232602af900ad1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","IMVT","BK4139","IMVTW","IMVTU","BK4585"],"gpt_icon":0},{"id":"2446313713","title":"Immunovant, Inc.盘中异动 快速下跌5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446313713","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446313713?lang=zh_cn&edition=full","pubTime":"2024-06-27 00:20","pubTimestamp":1719418842,"startTime":"0","endTime":"0","summary":"北京时间2024年06月27日00时20分，Immunovant, Inc.股票出现异动，股价急速下跌5.09%。截至发稿，该股报25.90美元/股，成交量61.4893万股，换手率0.42%，振幅4.67%。Immunovant, Inc.股票所在的生物技术行业中，整体跌幅为1.01%。其相关个股中，Anew Medical, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Diamedica Therapeutics Inc.涨幅较大，Anew Medical, Inc.、Cns Pharmaceuticals, Inc.、Gri Bio, Inc.较为活跃，换手率分别为673.35%、151.90%、108.22%，振幅较大的相关个股有Anew Medical, Inc.、Effector Therapeutics Inc C/Wts 31/12/2025 、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 ，振幅分别为112.12%、51.85%、45.14%。Immunovant, Inc.公司简介：Immunovant Inc.是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627002042968171f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627002042968171f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMVT","BK4585","BK4139","BK4588","IMVTU","IMVTW"],"gpt_icon":0},{"id":"2440946665","title":"Immunovant, Inc.盘中异动 下午盘急速跳水5.07%报25.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2440946665","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440946665?lang=zh_cn&edition=full","pubTime":"2024-06-01 01:53","pubTimestamp":1717177981,"startTime":"0","endTime":"0","summary":"北京时间2024年06月01日01时53分，Immunovant, Inc.股票出现异动，股价急速下跌5.07%。截至发稿，该股报25.07美元/股，成交量131.51万股，换手率0.90%，振幅5.30%。Immunovant, Inc.股票所在的生物技术行业中，整体涨幅为0.41%。Immunovant, Inc.公司简介：Immunovant Inc.是一家临床阶段的生物制药公司。消息层面，截至01时53分，《坎托菲茨杰拉德公司：重申Immunovant增持评级。》资讯为影响Immunovant, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240601015301af8b6bb7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240601015301af8b6bb7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4139","IMVT","IMVTU","BK4588","IMVTW"],"gpt_icon":0},{"id":"2439964387","title":"Immunovant Inc：古根海姆将目标价格从50美元下调至48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2439964387","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439964387?lang=zh_cn&edition=full","pubTime":"2024-05-31 18:36","pubTimestamp":1717151778,"startTime":"0","endTime":"0","summary":"Immunovant Inc：古根海姆将目标价格从50美元下调至48美元","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405311836189f0a4db5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405311836189f0a4db5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMVT"],"gpt_icon":0},{"id":"2439453624","title":"坎托菲茨杰拉德公司：重申Immunovant(IMVT.US)增持评级。","url":"https://stock-news.laohu8.com/highlight/detail?id=2439453624","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439453624?lang=zh_cn&edition=full","pubTime":"2024-05-30 23:55","pubTimestamp":1717084523,"startTime":"0","endTime":"0","summary":"坎托菲茨杰拉德公司：重申Immunovant(IMVT.US)增持评级。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405302355279f061cd1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405302355279f061cd1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMVT"],"gpt_icon":0},{"id":"2439426556","title":"Immunovant, Inc.盘中异动 早盘快速跳水9.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2439426556","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439426556?lang=zh_cn&edition=full","pubTime":"2024-05-30 21:31","pubTimestamp":1717075900,"startTime":"0","endTime":"0","summary":"北京时间2024年05月30日21时31分，Immunovant, Inc.股票出现异动，股价急速下挫9.84%。截至发稿，该股报26.66美元/股，成交量11.4432万股，换手率0.08%，振幅3.58%。Immunovant, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。其相关个股中，Kintara Therapeutics, Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Genfit涨幅较大，Kintara Therapeutics, Inc.、Mustang Bio, Inc.、Onconetix, Inc.较为活跃，换手率分别为31.38%、21.97%、16.12%，振幅较大的相关个股有Fresh2 Group Limited、Kintara Therapeutics, Inc.、Biocardia, Inc.，振幅分别为8.11%、7.17%、7.15%。Immunovant, Inc.公司简介：Immunovant Inc.是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240530213140957a98cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240530213140957a98cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","IMVT","BK4139","IMVTW","IMVTU","BK4585"],"gpt_icon":0},{"id":"2439593520","title":"Immunovant, Inc.盘中异动 急速上涨9.82%报31.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2439593520","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439593520?lang=zh_cn&edition=full","pubTime":"2024-05-29 21:30","pubTimestamp":1716989404,"startTime":"0","endTime":"0","summary":"北京时间2024年05月29日21时30分，Immunovant, Inc.股票出现波动，股价快速上涨9.82%。截至发稿，该股报31.21美元/股，成交量20.1273万股，换手率0.14%，振幅0.00%。Immunovant, Inc.股票所在的生物技术行业中，整体跌幅为1.55%。其相关个股中，Scorpius Holdings, Inc.、Ikena Oncology, Inc.、Immunovant, Inc.涨幅较大，Mustang Bio, Inc.、Scorpius Holdings, Inc.、Kintara Therapeutics, Inc.较为活跃，换手率分别为71.43%、62.43%、6.33%，振幅较大的相关个股有Nanoviricides, Inc.、Immunitybio, Inc.、Zymeworks Inc.，振幅分别为5.91%、1.06%、0.00%。Immunovant, Inc.公司简介：Immunovant Inc.是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024052921300496810839&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024052921300496810839&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMVTW","BK4588","BK4585","IMVTU","BK4139","IMVT"],"gpt_icon":0},{"id":"2434858445","title":"Immunovant Inc   预计每股亏损43美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2434858445","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434858445?lang=zh_cn&edition=full","pubTime":"2024-05-10 20:10","pubTimestamp":1715343043,"startTime":"0","endTime":"0","summary":"   * Immunovant Inc    预计在5月13日公布截至2024年3月31日的业绩时，季度收入将没有变化(预计)。*    * LSEG分析师对Immunovant公司的平均预期是每股亏损43美分。* 华尔街对 Immunovant Inc 的 12 个月目标价中位数为 51.00 美元，高于其上次收盘价 29.70 美元。5月10日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMVT"],"gpt_icon":0},{"id":"2428234115","title":"Immunovant, Inc.盘中异动 快速下跌5.00%报28.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428234115","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2428234115?lang=zh_cn&edition=full","pubTime":"2024-04-17 22:18","pubTimestamp":1713363487,"startTime":"0","endTime":"0","summary":"北京时间2024年04月17日22时18分，Immunovant, Inc.股票出现异动，股价快速下跌5.00%。截至发稿，该股报28.88美元/股，成交量17.5682万股，换手率0.12%，振幅4.78%。Immunovant, Inc.股票所在的生物技术行业中，整体涨幅为0.74%。Immunovant, Inc.公司简介：Immunovant Inc.是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240417221808861e6bad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240417221808861e6bad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4588","IMVTW","IMVTU","BK4585","IMVT"],"gpt_icon":0},{"id":"2421025459","title":"BUZZ-竞争对手中外制药的数据不尽如人意，Immunovant 和 Argenx 的业绩上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2421025459","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2421025459?lang=zh_cn&edition=full","pubTime":"2024-03-22 00:04","pubTimestamp":1711037051,"startTime":"0","endTime":"0","summary":"    3月21日 - ** 在日本中外制药公司  报告了其自身免疫性疾病药物satralizumab的后期数据后，Immunovant  的股价上涨2.5%至32.36美元，在美国上市的Argenx  的股价上涨12.3%至401美元。** 券商 Stifel 表示，由于该药物之前的研究数据令人印象深刻，因此该数据一直是 ARGX 和 IMVT 的主要障碍。** ARGX公司的Vyvgrat已被批准用于治疗这种疾病，而IMVT公司的实验性疗法正处于后期研究阶段。** Viridian Therapeutics    和 Tourmaline Bio    的股价分别下跌了 38.8% 和 38.8%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IMVT","VRDN","TRML","BUZZ"],"gpt_icon":0},{"id":"2419607011","title":"Immunovant, Inc.盘中异动 早盘股价大跌5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419607011","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2419607011?lang=zh_cn&edition=full","pubTime":"2024-03-14 21:59","pubTimestamp":1710424784,"startTime":"0","endTime":"0","summary":"北京时间2024年03月14日21时59分，Immunovant, Inc.股票出现异动，股价大幅下跌5.31%。截至发稿，该股报30.13美元/股，成交量10.7659万股，换手率0.07%，振幅5.28%。Immunovant, Inc.股票所在的生物技术行业中，整体跌幅为0.31%。其相关个股中，知临集团、Revolution Medicines Inc C/Wts 17/12/2026 、Nutriband Inc C/Wts 涨幅较大，知临集团、Novabay Pharmaceuticals, Inc.、Gri Bio, Inc.较为活跃，换手率分别为325.33%、137.79%、67.12%，振幅较大的相关个股有知临集团、Nuvectis Pharma, Inc.、180 Life Sciences Corp C/Wts 07/11/2025，振幅分别为73.90%、46.47%、41.94%。Immunovant, Inc.公司简介：Immunovant Inc.是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240314215945791a7ceb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240314215945791a7ceb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMVTU","IMVT","BK4139","IMVTW"],"gpt_icon":0},{"id":"2416057904","title":"Immunovant, Inc.盘中异动 急速下跌5.08%报35.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2416057904","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2416057904?lang=zh_cn&edition=full","pubTime":"2024-03-01 01:37","pubTimestamp":1709228265,"startTime":"0","endTime":"0","summary":"北京时间2024年03月01日01时37分，Immunovant, Inc.股票出现波动，股价快速下跌5.08%。截至发稿，该股报35.75美元/股，成交量30.8892万股，换手率0.21%，振幅6.73%。Immunovant, Inc.股票所在的生物技术行业中，整体跌幅为1.54%。其相关个股中，Enveric Biosciences, Inc.、Cingulate Inc C/Wts 10/12/2026 、Revance Therapeutics, Inc.涨幅较大，Enveric Biosciences, Inc.、Adial Pharmaceuticals, Inc、Revelation Biosciences, Inc.较为活跃，换手率分别为5805.57%、1569.54%、97.36%，振幅较大的相关个股有Carmell Corp C/Wts 12/07/2028 、Enveric Biosciences, Inc.、Ys Biopharma Co Ltd C/Wts 15/03/2028 ，振幅分别为164.60%、160.05%、95.99%。Immunovant, Inc.公司简介：Immunovant Inc.是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403010137457a483791&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403010137457a483791&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMVTW","IMVT","BK4139","IMVTU"],"gpt_icon":0},{"id":"2412491731","title":"美国研究综述-波尔、Couchbase、霍利","url":"https://stock-news.laohu8.com/highlight/detail?id=2412491731","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2412491731?lang=zh_cn&edition=full","pubTime":"2024-02-20 15:28","pubTimestamp":1708414083,"startTime":"0","endTime":"0","summary":"    路透社2月20日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价，其中包括 Ball、Couchbase 和 Holley。* Couchbase Inc   ：巴克莱将其评级从 \"增持 \"下调至 \"等权重\"。* Couchbase Inc   ：巴克莱将目标价从26美元上调至29美元              * Digital Realty Trust Inc   ：摩根大通将目标价从125美元上调至140美元              * Holley Inc   ：摩根大通将目标价从6.5美元下调至5美元              * 霍利公司  ：摩根大通将其评级从 \"增持 \"下调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRM","AVBP","MVBF","SG9999001176.SGD","TOST","LU2023250843.SGD","BK4213","LU1551013342.USD","DLR","Z","INTU","BK4084","BHF","LU0980610538.SGD","BASE","LU2361045086.USD","SG9999015341.SGD","TROX","LU2361044865.SGD","APPF","YELP","LU0511384066.AUD","HLLY","LU1989764664.SGD","LU0211331839.USD","LU2361044949.HKD","WDAY","MRK","BALL","LU1989772923.USD","KOS","BK4023","LYFT","RXST","IE00BJJMRZ35.SGD","LU1066051498.USD","LU2461242641.AUD","LU1989763005.USD","SSNC","BK4527","LU1201861249.SGD","MSDL","LU1989764748.USD","PPG","BK4079","LU1823568750.SGD","HOUS","IMVT","SKIL","BK4211"],"gpt_icon":0},{"id":"2407351402","title":"Immunovant Inc   预计每股亏损43美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2407351402","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2407351402?lang=zh_cn&edition=full","pubTime":"2024-01-30 21:53","pubTimestamp":1706622819,"startTime":"0","endTime":"0","summary":"   * Immunovant Inc    预计在2月1日公布截至2023年12月31日的业绩时，季度收入将没有变化(预计)。*    * LSEG分析师对Immunovant公司的平均预期是每股亏损43美分。* 华尔街对 Immunovant Inc 的 12 个月目标价中位数为 51.00 美元，高于其上次收盘价 39.32 美元。1月30日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMVT"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.immunovant.com","stockEarnings":[{"period":"1week","weight":-0.0851},{"period":"1month","weight":0.068},{"period":"3month","weight":-0.0089},{"period":"6month","weight":-0.3072},{"period":"1year","weight":0.214},{"period":"ytd","weight":-0.3361}],"compareEarnings":[{"period":"1week","weight":-0.0196},{"period":"1month","weight":0.0009},{"period":"3month","weight":0.1087},{"period":"6month","weight":0.138},{"period":"1year","weight":0.2141},{"period":"ytd","weight":0.155}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Immunovant, Inc.于2018年12月6日在特拉华州注册成立,是一家临床阶段生物制药公司，专注于为自身免疫性疾病患者提供正常生活。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.094855},{"month":2,"riseRate":0,"avgChangeRate":-0.169332},{"month":3,"riseRate":0.2,"avgChangeRate":-0.041053},{"month":4,"riseRate":0.4,"avgChangeRate":-0.020694},{"month":5,"riseRate":0.4,"avgChangeRate":0.099229},{"month":6,"riseRate":0.2,"avgChangeRate":-0.098266},{"month":7,"riseRate":0.5,"avgChangeRate":0.039412},{"month":8,"riseRate":0.6,"avgChangeRate":0.117177},{"month":9,"riseRate":1,"avgChangeRate":0.165149},{"month":10,"riseRate":0.6,"avgChangeRate":0.20936},{"month":11,"riseRate":0.8,"avgChangeRate":0.09369},{"month":12,"riseRate":0.8,"avgChangeRate":0.198952}],"exchange":"NASDAQ","name":"Immunovant, Inc.","nameEN":"Immunovant, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Immunovant, Inc.(IMVT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Immunovant, Inc.(IMVT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Immunovant, Inc.,IMVT,Immunovant, Inc.股票,Immunovant, Inc.股票老虎,Immunovant, Inc.股票老虎国际,Immunovant, Inc.行情,Immunovant, Inc.股票行情,Immunovant, Inc.股价,Immunovant, Inc.股市,Immunovant, Inc.股票价格,Immunovant, Inc.股票交易,Immunovant, Inc.股票购买,Immunovant, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Immunovant, Inc.(IMVT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Immunovant, Inc.(IMVT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}